Navigation Links
Nobel Prize Awarded to Foundation for Biomedical Research Board Member
Date:10/10/2007

WASHINGTON, Oct. 10 /PRNewswire-USNewswire/ -- The Foundation for Biomedical Research (FBR) congratulates Mario R. Capecchi today for the richly deserved honor of the 2007 Nobel Prize in Physiology or Medicine. Capecchi, who sits on FBR's Board of Governors, is currently a Distinguished Professor and Co-Chair of the Human Genetics Department at the University of Utah, School of Medicine.

"Groundbreaking research such as Dr. Capecchi's has enabled the study of diseases in a way never before thought possible," said FBR President Frankie L. Trull. "This further demonstrates the incredible power and promise of the humane use of animal models in medical research."

The Nobel Foundation recognized Capecchi and two other researchers for the discovery of "principles for introducing specific gene modifications in mice by the use of embryonic stem cells." Their studies resulted in genetically altered mouse models, innovating the way researchers work to combat such diseases as cancer, diabetes and Alzheimer's.

Capecchi's Nobel Prize-winning work involved gene targeting in mouse embryonic stem cells, allowing scientists to study the pathology of disease in a living system whose genes have been either inactivated or modified. Scientists can now target specific disease-causing genes in an effort to discover new cures or treatments that afflict both humans and animals.

Upon joining FBR's Board of Governors, Capecchi said, "I am a very strong advocate for the respect and support of animal research. My scientific life has been devoted to the use of mouse models for the understanding of the development of therapies of human disease as well as for the pathologies."

FBR's Board of Governors now includes ten Nobel Laureates. Capecchi is a recipient of numerous other awards, including the Albert Lasker Award in 2001.

FBR is the nation's foremost organization devoted to promoting public understanding, respect, and support for the humane and responsible use of animals in medical and scientific research. For more information on FBR, please visit its Web site at http://www.fbresearch.org.


'/>"/>
SOURCE Foundation for Biomedical Research
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Vastox Awarded £400,000 Grant to Support R&D at Carbohydrate Chemistry Facility
2. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
3. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
4. The Christopher and Dana Reeve Foundation Expresses Disappointment Over President Bushs Veto of the Stem Cell Research Enhancement Act
5. Hypertension Education Foundation Survey Results Announced At American Society For Hypertension Annual Meeting Suggests Improved Control Of High Blood Pressure, But Misconceptions Still Exist
6. The International Myeloma Foundation Reports Positive Shift In Treatment Paradigm For Patients
7. Research Supported by Samuel Waxman Cancer Research Foundation Discovers Mode of Action of Arsenic-Based Drugs in Destroying Cancer Cells
8. The International Myeloma Foundation Says New Clinical Trial Results Could Improve Survival While Reducing Side Effects For Many Patients
9. The American Liver Foundation Urges Cautious Optimism about CDC Report on Declining Acute Hepatitis Infection Rates
10. Advanced Magnetics Announces Presentation of Ferumoxytol Data at the National Kidney Foundation 2007 Spring Clinical Meetings
11. Vical Interim Clinical Results Demonstrate Safety and Tolerability of Inovio Biomedicals Electroporation DNA Delivery Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... March 22, 2017 Under the impetus ... packaging market size increased year by year at ... to 2021, the market size will maintain the ... to outnumber RMB140 billion in 2021, thanks to ... development of biological agents and supporting policies. ...
(Date:3/22/2017)... March 22, 2017 New Jersey,s ... of patient harm and saved $641 million in healthcare ... in a national quality improvement program. ... for Patients-New Jersey, part of a national initiative from ... selected the New Jersey Hospital Association and its affiliate, ...
(Date:3/22/2017)... Mar 22, 2017 Research and Markets ... Point Inhibitors Market & Clinical Pipeline Insight 2022" drug ... ... & Clinical Pipeline Insight 2022 report gives comprehensive insight on ... of immune check point inhibitors as main streamline drugs in ...
Breaking Medicine Technology:
(Date:3/22/2017)... Jacksonville, FL (PRWEB) , ... March 22, 2017 ... ... (ASPC) convened experts to create a PCSK9 inhibitor prior authorization (PA) form for ... high cholesterol. It is one of the helpful tools published as part of ...
(Date:3/22/2017)... ... 22, 2017 , ... Wash Tower Ltd. has released a series of six ... the world's first standalone constant pressure bidet. , The videos in the series titled ... https://www.washtower.com as well as on its social media pages. , Each video stars ...
(Date:3/22/2017)... ... 22, 2017 , ... University Orthopedics (UOI) today announced the ... Hand, Upper Extremity and Microvascular Surgery at Newport Hospital. Dr. Bragdon specializes in ... and Hand Surgery. , As the leader of comprehensive orthopedic care in ...
(Date:3/22/2017)... ... March 22, 2017 , ... SNL Insurance and Financial, a ... business owners in the greater Hampton Roads area, is embarking on a community ... Life event. , Each year, hundreds of people living in the South Hampton ...
(Date:3/22/2017)... , ... March 22, 2017 , ... ... planning assistance, and related services to families and business owners in the greater ... with the Leukemia & Lymphoma Society. , Every 3 minutes, someone in America ...
Breaking Medicine News(10 mins):